FDA Inspection
Biomat USA IncBiomat USA Inc – FDA Inspection, May 6, 2010
Record Details
This FDA Inspection record concerns Biomat USA Inc, with an inspection on May 6, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Biomat USA Inc
- Inspection Date
- May 6, 2010
- Product Type
- Biologics
View Company Profile
ID · 1d5c08b1-1168-44b6-8abe-76086c166918
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 661175
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA Inc
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 27, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 25, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 17, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 15, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 17, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA Inc
- FDA Inspection 1062339 - 2018-07-27
- FDA Inspection 950741 - 2015-11-25
- FDA Inspection 887239 - 2014-07-17
- FDA Inspection 855254 - 2013-11-15
- FDA Inspection 794963 - 2012-08-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.